The PCC is pleased to present a new infographic showcasing the consortium’s mission, achievements, and future priorities in advancing precision oncology worldwide.

The infographic highlights how the PCC is working through global collaboration to make biomarker-informed, data-driven patient identification and personalized care standard practice. It outlines the challenges that continue to limit access to precision oncology and demonstrates how collective action across the healthcare ecosystem can help overcome these barriers.

Key topics featured in the infographic include:

• The PCC’s vision to make precision oncology the new normal for patients worldwide
• Current initiatives to improve access to comprehensive genomic profiling (CGP) and liquid biopsy (LBx) testing
• Overview of educational activities designed to support healthcare professionals
• Free tools developed to support biomarker testing implementation
• Key focus areas and ambitions for 2026–2027

The infographic also explores why organisations choose to engage with or join the PCC, highlighting the opportunity to shape the future of biomarker testing, demonstrate commitment to improving patient outcomes, and maximize the impact of shared expertise and resources.

Download the infographic to learn more about the PCC, its global initiatives, and its vision for accelerating access to precision oncology.